Clindamycin

Research use only, not for human use.

Clindamycin inhibits protein synthesis by acting on the 50S ribosomal.

Clindamycin inhibits protein synthesis by acting on the 50S ribosomal.

Cell Viability Assay Cell Line:THP-1 cells with stimulated E. coli O55:B5 Concentration:3.13-50 μg/mL Incubation Time:1-18 h Result:Reduced TNF-α concentrations after pretreatment for 4 or 18 h at 25 and 50 μg/mL.Cell Viability Assay Cell Line:Osteoblast cell culture model Concentration:0-500 μg/mL Incubation Time:24-72 h Result:Increased alkaline phosphatase (ALP)-activity at 10 μg/mL at 24 and 48 h.Increased LDH values at 500 μg/mL at 24 and 48 h, indicating cytotoxicity.Increased calcification at 10 and 25 μg/mL,decreased or no calcification was found at 50 μg/ml.

——

U 21251

Others

Other Targets

Others

Other Indications

——

18323-44-9

424.98

C18H33ClN2O5S

>98% (HPLC)

DMSO:85 mg/mL (200.0 mM); Ethanol:85 mg/mL (200.0 mM); Water:<1 mg/mL (<1 mM)

CCC[C@@H]1C[C@@H](C(N[C@@H]([C@H]2O[C@@H]([C@@H]([C@H]([C@H]2O)O)O)SC)[C@@H](Cl)C)=O)N(C1)C

(2S,4R)-N-((1S,2S)-2-chloro-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide

(-20℃)

With Ice Pack

≥ 2 years